{'fraction_non_alphanumeric': 0.02203856749311295, 'fraction_numerical': 0.015610651974288337, 'mean_word_length': 5.089385474860335, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Lymphoblast proliferation and humoral antibody response after rubella vaccination.

Twenty-eight sero-negative young women were vaccinated with RA 27/3 or HPV-77/DE5 strain live attenuated rubella vaccine. Haemagglutination-inhibiting antibody developed in all but one of the subjects. Rubella-specific IgM antibodies were demonstrable 3–6 weeks after vaccination. Complement-fixing and platelet-aggregation antibodies were more often detectable after RA 27/3 than after HPV-77/DE5 vaccination. After vaccination the blood lymphoblast count increased with a peak at 2 weeks. In one subject no humoral antibody response was detectable but even in this case there was a lymphoblast response. A marked increase in blasts was detected in a single case of natural rubella infection. In the vaccinated subjects the tuberculin skin test did not reveal suppression of delayed hypersensitivity 3 weeks after vaccination, nor was there a change in the responsiveness of lymphocytes to PHA in vitro 2 weeks after vaccination. No significant decrease in platelet count was seen in any of the subjects.